Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people ...

MAIA Biotechnology, Inc., (NYSE American: MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that an abstract ...

Immutep (IMMP) announces an upcoming poster presentation for the TACTI-004 Phase III trial. The poster will be presented at the European Lung ...

today announced two abstracts accepted for poster presentations at the upcoming European Lung Cancer Congress (ELCC) 2025 Scientific Committee and Mayo Clinic Multidisciplinary Head and Neck ...

Dolan’s grievances with the NBA and its commissioner Adam Silver have continued to mount. What could come next?

The Trial in Progress poster includes an overview and study design of the TACTI-004 Phase III evaluating the Company’s MHC Class II agonist, eftilagimod alfa (efti) in combination with MSD’s (Merck & ...

A Nintendo Direct about the Switch 2 is coming next week, but Nintendo might have a Switch 1 presentation on tap for this ...

Now in its seventh year, Minnesota State University will hold its Health Summit on Wednesday focusing on the theme ...

A hearing was held Tuesday morning by the Senate Education Committee on a proposed bill that would require Missouri school ...

Rumors suggest that a Nintendo Direct will happen on Wednesday, March 26th, one week before next week's Switch 2 presentation ...

ELRIG, a not-for-profit, volunteer-led organization for the drug discovery community, today announced the keynote speakers for Therapeutic Oligonucleotides 2025 taking place at the AstraZeneca R&D ...